CSL will consolidate its R&D teams around six sites located in biotech hubs as the company looks to boost external partnerships. (iStock/Getty Images Plus) CSL is consolidating its R&D team in an ...

CSL's stunning fall has investors questioning its comeback prospects. The post Once untouchable, now unloved: What's up with ...

CSL is coming for one of Takeda’s fastest-growing products. Phase 3 data on CSL’s garadacimab in a rare disease suggest the monoclonal antibody may have an edge over Takeda’s Takhzyro in terms of ...

Good morning, everyone, and welcome to CSL's Financial Year 2024 Results Presentation. I'm Joy Linton, CSL's Chief Financial Officer. And before we begin the formalities today, I would like to say a ...

Dave Ross - Senior Vice President and General Manager, CSL Seqirus Hervé Gisserot - Senior Vice President and General Manager, CSL Vifor Thank you for standing by and welcome to the CSL Limited Half ...